1 | .Nusinersen | 1件: Nusinersen Nusinersen | 1件: D10881
D10881
| 1件: SMN2 SMN2 💬 | - | 1件: 3 3 |
2 | 0000 | - | - | - | - | 1件: 3 3 |
3 | 2011-2012 seasonal flu vaccine Intramuscular | - | - | - | - | 2件: 3 3, 113 |
4 | 2011-2012 seasonal flu vaccine Subcutaneous | - | - | - | - | 2件: 3 3, 113 |
5 | 3,4-Diaminopyridine Phosphate | 1件: Phosphate ion Phosphate ion | - | - | - | 1件: 3 3 |
6 | 4-Aminopyridine | 1件: Dalfampridine Dalfampridine | 1件: D04127
D04127
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 2件: 3 3, 13 |
7 | 4-cholesten-3-one, oxime | - | - | - | - | 2件: 2 2, 3 |
8 | 4-cholesten-3-one,oxime | - | - | - | - | 1件: 3 3 |
9 | Adipose derived mesenchymal stem cell | - | - | - | - | 1件: 3 3 |
10 | AMIFAMPRIDINA | - | - | - | - | 2件: 3 3, 11 |
11 | Amifampridina fosfato | - | - | - | - | 2件: 3 3, 11 |
12 | Amifampridine | 1件: Amifampridine Amifampridine | 1件: D10228
D10228
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 3件: 3 3, 11, 12 |
13 | Amifampridine Phosphate | 2件: Amifampridine Amifampridine, Phosphate ion | 1件: D10228
D10228
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 3件: 3 3, 11, 12 |
14 | Amifampridine Phosphate 10 MG Oral Tablet | 2件: Amifampridine Amifampridine, Phosphate ion | 1件: D10228
D10228
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 3 3 |
15 | Apitegromab | 1件: Apitegromab Apitegromab | 1件: D11797
D11797
| 1件: MSTN MSTN 💬 | 1件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | 1件: 3 3 |
16 | AVXS-101 | - | - | - | - | 1件: 3 3 |
17 | AVXS-101 (previously known as scAAV9.CB.SMN) | - | - | - | - | 1件: 3 3 |
18 | Biocarn | - | - | - | - | 1件: 3 3 |
19 | Branaplam | 1件: Branaplam Branaplam | 1件: D12272
D12272
| 1件: SMN2 SMN2 💬 | - | 2件: 3 3, 8 |
20 | Celecoxib | 1件: Celecoxib Celecoxib | 1件: D00567
D00567
| 1件: PTGS2 PTGS2 💬 | 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 10件: 2 2, 3, 34, 46, 70, 89, 107, 161, 171, 271 |
21 | Disease modifying treatments | - | - | - | - | 1件: 3 3 |
22 | EVRYSDI | 1件: Risdiplam Risdiplam | 1件: D11406
D11406
| 1件: SMN2 SMN2 💬 | 1件: Nucleocytoplasmic transport Nucleocytoplasmic transport 💬 | 1件: 3 3 |
23 | EXG001-307 injection | - | - | - | - | 1件: 3 3 |
24 | Firdapse | 1件: Amifampridine Amifampridine | 1件: D10228
D10228
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 2件: 3 3, 11 |
25 | FIRDAPSE - 10 MG - COMPRESSE - USO ORALE - BLISTER(ALU/PVC/PVDC) 100 X 1 COMPRESSE | 1件: Amifampridine Amifampridine | 1件: D10228
D10228
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 2件: 3 3, 11 |
26 | GH | - | - | - | - | 1件: 3 3 |
27 | GYM329 | - | - | - | - | 1件: 3 3 |
28 | HUMAN ANTI-PROMYOSTATIN MONOCLONAL ANTIBODY | - | - | - | - | 1件: 3 3 |
29 | Hydroxyurea | 1件: Hydroxyurea Hydroxyurea | 1件: D00341
D00341
| 1件: RRM2 RRM2 💬 | 7件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway 💬 | 8件: 3 3, 13, 19, 20, 65, 85, 86, 284 |
30 | ISIS 396443 | - | - | - | - | 1件: 3 3 |
31 | ISIS 396443 (BIIB058) | - | - | - | - | 1件: 3 3 |
32 | ISIS 396443, BIIB058 | - | - | - | - | 1件: 3 3 |
33 | Itraconazole | 1件: Itraconazole Itraconazole | 1件: D00350
D00350
| - | - | 6件: 3 3, 46, 65, 96, 227, 299 |
34 | Leuprolide | 1件: Leuprolide Leuprolide | - | - | - | 5件: 1 1, 2, 3, 51, 76 |
35 | LEVOCARNITINE | 1件: Levocarnitine Levocarnitine | 1件: D02176
D02176
| - | - | 3件: 3 3, 53, 97 |
36 | LMI070 | - | - | - | - | 2件: 3 3, 8 |
37 | Mestinon | 1件: Pyridostigmine Pyridostigmine | - | - | - | 3件: 3 3, 6, 11 |
38 | Midazolam | 1件: Midazolam Midazolam | 1件: D00550
D00550
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 |
39 | N.a. | - | - | - | - | 10件: 3 3, 6, 8, 13, 46, 96, 97, 240, 256, 271 |
40 | Nerve Growth Factor | 1件: Nerve Growth Factor Nerve Growth Factor | - | - | - | 3件: 3 3, 53, 90 |
41 | Norditropin SimpleXx | - | - | - | - | 5件: 3 3, 78, 107, 193, 195 |
42 | Norditropin SimpleXx 15 mg/1.5 ml | 1件: Somatotropin Somatotropin | - | - | - | 1件: 3 3 |
43 | Nursinersen | - | - | - | - | 1件: 3 3 |
44 | NUSINERSEN | 1件: Nusinersen Nusinersen | 1件: D10881
D10881
| 1件: SMN2 SMN2 💬 | - | 1件: 3 3 |
45 | Nusinersen Injectable Product | 1件: Nusinersen Nusinersen | 1件: D10881
D10881
| 1件: SMN2 SMN2 💬 | - | 1件: 3 3 |
46 | NUSINERSEN SODIUM | 1件: Nusinersen Nusinersen | 1件: D10881
D10881
| 1件: SMN2 SMN2 💬 | - | 1件: 3 3 |
47 | Nusinersen Treatments | 1件: Nusinersen Nusinersen | 1件: D10881
D10881
| 1件: SMN2 SMN2 💬 | - | 1件: 3 3 |
48 | OAV101 | - | - | - | - | 1件: 3 3 |
49 | Okrido | - | - | - | - | 1件: 3 3 |
50 | Okrido 6mg/mL oral solution | - | - | - | - | 1件: 3 3 |
51 | Olesoxime | 1件: Olesoxime Olesoxime | 1件: D11213
D11213
| - | - | 3件: 2 2, 3, 13 |
52 | ONASEMNOGENE ABEPARVOVEC | 1件: Onasemnogene abeparvovec Onasemnogene abeparvovec | 1件: D11559
D11559
| 1件: SMN1 SMN1 💬 | - | 1件: 3 3 |
53 | Onasemnogene Abeparvovec-xioi | 1件: Onasemnogene abeparvovec Onasemnogene abeparvovec | 1件: D11559
D11559
| 1件: SMN1 SMN1 💬 | - | 1件: 3 3 |
54 | Orfiril Saft | - | - | - | - | 1件: 3 3 |
55 | PARACETAMOL | 1件: Acetaminophen Acetaminophen | 1件: D00217
D00217
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 6件: 3 3, 6, 13, 35, 46, 49 |
56 | Paracetamol 120Mg/5mL Oral Suspension | 1件: Acetaminophen Acetaminophen | 1件: D00217
D00217
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 3 3 |
57 | PHENYLBUTYRATE | 1件: Phenylbutyric acid Phenylbutyric acid | - | - | - | 12件: 2 2, 3, 6, 8, 15, 93, 94, 244, 251, 297, 299, 338 |
58 | Phosphate | 1件: Phosphate ion Phosphate ion | - | - | - | 32件: 2 2, 3, 6, 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 238, 256, 276, 283, 284, 285, 286, 299 |
59 | Placebo | - | - | - | - | 28件: 3 3, 5, 6, 11, 13, 14, 37, 40, 46, 49, 50, 51, 53, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 |
60 | PREDNISOLONE | 1件: Prednisolone Prednisolone | 1件: D00472
D00472
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 42件: 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300 |
61 | PREDNISOLONE SODIUM PHOSPHATE | 2件: Phosphate ion Phosphate ion, Prednisolone | 1件: D00472
D00472
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 3 3, 13, 97 |
62 | Previously termed sc.AAV9.CB.SMN and AVXS-101 | - | - | - | - | 1件: 3 3 |
63 | Pyridostigmine | 1件: Pyridostigmine Pyridostigmine | - | - | - | 4件: 3 3, 6, 11, 256 |
64 | Pyridostigmine Bromide | 1件: Pyridostigmine Pyridostigmine | - | - | - | 3件: 3 3, 6, 256 |
65 | RELDESEMTIV | 1件: Reldesemtiv Reldesemtiv | 1件: D11363
D11363
| 1件: TNNC2 TNNC2 💬 | 1件: Calcium signaling pathway Calcium signaling pathway 💬 | 2件: 2 2, 3 |
66 | Reldesemtiv 150 mg | 1件: Reldesemtiv Reldesemtiv | 1件: D11363
D11363
| 1件: TNNC2 TNNC2 💬 | 1件: Calcium signaling pathway Calcium signaling pathway 💬 | 1件: 3 3 |
67 | Reldesemtiv 450 mg | 1件: Reldesemtiv Reldesemtiv | 1件: D11363
D11363
| 1件: TNNC2 TNNC2 💬 | 1件: Calcium signaling pathway Calcium signaling pathway 💬 | 1件: 3 3 |
68 | RILUZOLE | 1件: Riluzole Riluzole | 1件: D00775
D00775
| 14件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 23件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 |
69 | Risdiplam | 1件: Risdiplam Risdiplam | 1件: D11406
D11406
| 1件: SMN2 SMN2 💬 | 1件: Nucleocytoplasmic transport Nucleocytoplasmic transport 💬 | 1件: 3 3 |
70 | RO6885247 | - | - | - | - | 1件: 3 3 |
71 | RO6885247/F02 | - | - | - | - | 1件: 3 3 |
72 | RO6885247/F03 | - | - | - | - | 1件: 3 3 |
73 | RO7034067 | - | - | - | - | 1件: 3 3 |
74 | RO7034067 / F12 | - | - | - | - | 1件: 3 3 |
75 | RO7034067 / F13 | - | - | - | - | 1件: 3 3 |
76 | RO7034067/F06 + solvente (RO | - | - | - | - | 1件: 3 3 |
77 | RO7034067/F06 with solvent (RO7034067/F08) | - | - | - | - | 1件: 3 3 |
78 | RO7034067/F07 + solvente (RO | - | - | - | - | 1件: 3 3 |
79 | RO7034067/F07 with solvent (RO7034067/F09) | - | - | - | - | 1件: 3 3 |
80 | RO7034067/F12 | - | - | - | - | 1件: 3 3 |
81 | RO7034067/F13 | - | - | - | - | 1件: 3 3 |
82 | RO7090919 | - | - | - | - | 1件: 3 3 |
83 | RO7204239 | - | - | - | - | 2件: 3 3, 113 |
84 | RO7204239/F01-01 | - | - | - | - | 1件: 3 3 |
85 | RVG 03820 | - | - | - | - | 1件: 3 3 |
86 | Salbutamol | 1件: Salbutamol Salbutamol | 1件: D02147
D02147
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 8件: 3 3, 11, 49, 85, 86, 111, 256, 299 |
87 | Sesame oil | 1件: Sesame oil Sesame oil | 1件: D03314
D03314
| - | - | 1件: 3 3 |
88 | SESAME OIL, REFINED | 1件: Sesame oil Sesame oil | 1件: D03314
D03314
| - | - | 1件: 3 3 |
89 | SMART | - | - | - | - | 1件: 3 3 |
90 | Sodium phenylbutyrate | 1件: Phenylbutyric acid Phenylbutyric acid | - | - | - | 4件: 2 2, 3, 8, 251 |
91 | Sodium phenylbutyrate (NaPB) | 1件: Phenylbutyric acid Phenylbutyric acid | - | - | - | 1件: 3 3 |
92 | Somatotropin | 1件: Somatotropin Somatotropin | - | - | - | 4件: 3 3, 65, 78, 236 |
93 | Somatropin | 1件: Somatotropin Somatotropin | - | - | - | 19件: 2 2, 3, 19, 46, 65, 74, 75, 78, 96, 107, 113, 187, 193, 195, 238, 265, 274, 276, 299 |
94 | Spinraza | 1件: Nusinersen Nusinersen | 1件: D10881
D10881
| 1件: SMN2 SMN2 💬 | - | 1件: 3 3 |
95 | SRK-015 | - | - | - | - | 1件: 3 3 |
96 | Sulfate | 1件: Sulfate ion Sulfate ion | - | - | - | 27件: 2 2, 3, 6, 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 85, 86, 96, 111, 218, 222, 224, 226, 265, 296, 297, 299 |
97 | Survival of Motor Neuron 2 (SMN2) Splicing Modulator Antisense Oligonucleotide | - | - | - | - | 1件: 3 3 |
98 | Taldefgrobep alfa | 1件: Talditercept alfa Talditercept alfa | 1件: D11265
D11265
| 1件: MSTN MSTN 💬 | 1件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | 1件: 3 3 |
99 | Testosterone | 1件: Testosterone Testosterone | 1件: D00075
D00075
| 1件: AR AR 💬 | 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 8件: 1 1, 2, 3, 13, 60, 76, 78, 113 |
100 | TRO19622 | - | - | - | - | 2件: 2 2, 3 |
101 | Valproate | 1件: Valproic acid Valproic acid | 1件: D00399
D00399
| 7件: ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | 17件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | 6件: 2 2, 3, 90, 102, 233, 256 |
102 | VALPROATE SODIUM | 1件: Valproic acid Valproic acid | 1件: D00399
D00399
| 7件: ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | 17件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | 1件: 3 3 |
103 | Valproate, Levocarnitine | 2件: Levocarnitine Levocarnitine, Valproic acid | 2件: D00399
D00399
,
D02176
| 7件: ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | 17件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | 1件: 3 3 |
104 | Valproic Acid | 1件: Valproic acid Valproic acid | 1件: D00399
D00399
| 7件: ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | 17件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | 7件: 3 3, 5, 26, 65, 90, 222, 256 |
105 | Valproic Acid (VPA) | 1件: Valproic acid Valproic acid | 1件: D00399
D00399
| 7件: ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | 17件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | 1件: 3 3 |
106 | Valproic Acid and Levocarnitine | 2件: Levocarnitine Levocarnitine, Valproic acid | 2件: D00399
D00399
,
D02176
| 7件: ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | 17件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | 1件: 3 3 |
107 | VOLMAX*30CPR 4MG R.P. | - | - | - | - | 1件: 3 3 |
108 | VPA | - | - | - | - | 1件: 3 3 |
109 | Zolgensma | 1件: Onasemnogene abeparvovec Onasemnogene abeparvovec | 1件: D11559
D11559
| 1件: SMN1 SMN1 💬 | - | 1件: 3 3 |
110 | Zolgensma 2 x 1013 vector genomes/mL solution for infusion | 1件: Onasemnogene abeparvovec Onasemnogene abeparvovec | 1件: D11559
D11559
| 1件: SMN1 SMN1 💬 | - | 1件: 3 3 |
111 | Zolgensma 2 x 1013 vg (vector genomes)/mL solution for infusion | 1件: Onasemnogene abeparvovec Onasemnogene abeparvovec | 1件: D11559
D11559
| 1件: SMN1 SMN1 💬 | - | 1件: 3 3 |